17-63918770-T-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_000515.5(GH1):​c.7A>C​(p.Thr3Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000281 in 1,613,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T3A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 0 hom. )

Consequence

GH1
NM_000515.5 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -1.06

Publications

10 publications found
Variant links:
Genes affected
GH1 (HGNC:4261): (growth hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]
GH1 Gene-Disease associations (from GenCC):
  • isolated growth hormone deficiency type IA
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • isolated growth hormone deficiency type II
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • isolated growth hormone deficiency type IB
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short stature due to growth hormone qualitative anomaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024536937).
BP6
Variant 17-63918770-T-G is Benign according to our data. Variant chr17-63918770-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 452376.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000394 (60/152284) while in subpopulation NFE AF = 0.000529 (36/68014). AF 95% confidence interval is 0.000392. There are 0 homozygotes in GnomAd4. There are 25 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GH1NM_000515.5 linkc.7A>C p.Thr3Pro missense_variant Exon 1 of 5 ENST00000323322.10 NP_000506.2
GH1NM_022559.4 linkc.7A>C p.Thr3Pro missense_variant Exon 1 of 5 NP_072053.1
GH1NM_022560.4 linkc.7A>C p.Thr3Pro missense_variant Exon 1 of 4 NP_072054.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GH1ENST00000323322.10 linkc.7A>C p.Thr3Pro missense_variant Exon 1 of 5 1 NM_000515.5 ENSP00000312673.5
ENSG00000285947ENST00000647774.1 linkc.287-264A>C intron_variant Intron 4 of 7 ENSP00000497443.1

Frequencies

GnomAD3 genomes
AF:
0.000394
AC:
60
AN:
152166
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000232
AC:
58
AN:
249884
AF XY:
0.000222
show subpopulations
Gnomad AFR exome
AF:
0.000254
Gnomad AMR exome
AF:
0.000290
Gnomad ASJ exome
AF:
0.000200
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.000301
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000269
AC:
393
AN:
1460778
Hom.:
0
Cov.:
35
AF XY:
0.000263
AC XY:
191
AN XY:
726758
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33422
American (AMR)
AF:
0.000179
AC:
8
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26128
East Asian (EAS)
AF:
0.000504
AC:
20
AN:
39700
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86236
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53420
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5752
European-Non Finnish (NFE)
AF:
0.000283
AC:
314
AN:
1111062
Other (OTH)
AF:
0.000315
AC:
19
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000394
AC:
60
AN:
152284
Hom.:
0
Cov.:
32
AF XY:
0.000336
AC XY:
25
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41534
American (AMR)
AF:
0.0000654
AC:
1
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000529
AC:
36
AN:
68014
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000119
Hom.:
1
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.000247
AC:
30

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Aug 11, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis suggests that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

not specified Benign:1
Dec 22, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: GH1 c.7A>C (p.Thr3Pro) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 249884 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in GH1 causing Idiopathic Growth Hormone Deficiency phenotype (6.3e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.7A>C in individuals affected with Idiopathic Growth Hormone Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17223997, 18950677). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
1.8
DANN
Benign
0.32
DEOGEN2
Benign
0.072
.;.;.;T;T;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.49
T;T;T;T;T;.
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.025
T;T;T;T;T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
-0.81
.;N;N;N;.;.
PhyloP100
-1.1
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.55
N;N;N;N;N;.
REVEL
Uncertain
0.33
Sift
Benign
0.65
T;T;T;T;T;.
Sift4G
Benign
0.26
T;T;T;T;T;D
Polyphen
0.0, 0.026, 0.044
.;.;.;B;B;B
Vest4
0.19
MVP
0.22
MPC
0.14
ClinPred
0.0013
T
GERP RS
-0.16
PromoterAI
-0.011
Neutral
Varity_R
0.10
gMVP
0.23
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2001345; hg19: chr17-61996130; API